Pseudomonas aeruginosa Biofilms in Cystic Fibrosis: Interactions, Methods, and Therapeutic Strategies
BioMed Research International · 2026-01 · 2026 (1)
DOI: 10.1155/bmri/5328382 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift BioMed Research International, online erschienen am 26.02.2026. Verfasst von Luis Ángel Núñez-García und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon, Mexico, uanl.mx. Hauptthemen laut MEDLINE: Cystic Fibrosis, Biofilms, Pseudomonas aeruginosa, Anti-Bacterial Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 175 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This review explores the role of Pseudomonas aeruginosa biofilms in cystic fibrosis (CF) pathogenesis. Biofilms, the main bacterial lifestyle in CF lungs, are key in therapy failure, immune evasion, and chronic infection persistence. This review examines biofilm structure, emphasizing extracellular polymeric substances (Psl, Pel, alginate, eDNA) and their roles in structural stability, resistance to antibiotics, and immune modulation. Regulatory mechanisms, including c‐di‐GMP signaling and quorum‐sensing systems, are detailed as key drivers of biofilm formation and maintenance. The review also highlights polymicrobial interactions, particularly with Staphylococcus aureus , Candida spp., and Aspergillus spp., and commensal bacteria, illustrating how interaction dynamics shape microbial behavior, virulence, and treatment outcomes. Methods for studying biofilms in CF‐like conditions, such as advanced in vitro models and transcriptomic analyses, are outlined for their relevance in replicating the complex lung environment. Emerging antibiofilm strategies, including matrix‐disrupting enzymes, quorum‐sensing inhibitors, bacteriophage therapies, and nanomedicine, are discussed as promising tools to combat biofilm resilience. The review underscores the need for innovative therapeutic approaches and a deeper understanding of microbial and host interactions to improve clinical outcomes in CF patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, Faculty of Medicine, Autonomous University of Nuevo Leon, Monterrey, Nuevo Leon, Mexico, uanl.mx.
ORCID-Profile: Luis Ángel Núñez-García, Carlos Córdova-Fletes, María Carmen Barboza-Cerda, Elvira Garza-González
Zitieren
APA
Núñez-García, L. Á., Córdova-Fletes, C., Barboza-Cerda, M. C., & Garza-González, E. (2026). Pseudomonas aeruginosa Biofilms in Cystic Fibrosis: Interactions, Methods, and Therapeutic Strategies. BioMed Research International, 2026(1). https://doi.org/10.1155/bmri/5328382
Vancouver
Núñez-García LÁ, Córdova-Fletes C, Barboza-Cerda MC, Garza-González E. Pseudomonas aeruginosa Biofilms in Cystic Fibrosis: Interactions, Methods, and Therapeutic Strategies. BioMed Research International. 2026;2026(1). doi:10.1155/bmri/5328382
BibTeX
@article{NezGarca2026,
author = {Núñez-García, Luis Ángel and Córdova-Fletes, Carlos and Barboza-Cerda, María Carmen and Garza-González, Elvira},
title = {Pseudomonas aeruginosa Biofilms in Cystic Fibrosis: Interactions, Methods, and Therapeutic Strategies},
journal = {BioMed Research International},
year = {2026},
volume = {2026},
number = {1},
doi = {10.1155/bmri/5328382}
}
EUVIMED